Efficacy of quercetin against chemically induced murine oral squamous cell carcinoma

Droguett,Daniel; Castillo,Christian; Leiva,Elba; Theoduloz,Cristina; Schmeda‑Hirschmann,Guillermo; Kemmerling,Ulrike

doi:10.3892/ol.2015.3598

Efficacy of quercetin against chemically induced murine oral squamous cell carcinoma

Authors:
- Daniel Droguett
- Christian Castillo
- Elba Leiva
- Cristina Theoduloz
- Guillermo Schmeda‑Hirschmann
- Ulrike Kemmerling
View Affiliations

Affiliations: Department of Stomatology, Faculty of Health Sciences, University of Talca, Talca 3460000, Chile, Program of Anatomy and Developmental Biology, Institute of Biomedical Sciences, Faculty of Medicine, University of Chile, Santiago 8380453, Chile, Department of Clinical Biochemistry and Immunohematology, Faculty of Health Sciences, University of Talca, Talca 3460000, Chile, Institute of Chemistry of Natural Resources, University of Talca, Talca 3460000, Chile
Published online on: August 12, 2015 https://doi.org/10.3892/ol.2015.3598
Pages: 2432-2438

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Oral squamous cell carcinoma (OSCC) is the most common form of head and neck cancer, and oxidative damage is associated with the development of OSCCs. Antioxidants have therefore been proposed for use as chemoprotective agents against different types of cancer. In the present study, the effect of the antioxidant quercetin, administered at doses of 10 and 100 mg/kg/day, was investigated in an experimental murine model of 4‑nitroquinoline 1‑oxide (4‑NQO)‑induced carcinogenesis. The survival of the treated animals, the plasmatic levels of reduced glutathione and the type and severity of lesions (according the International Histological Classification of Tumors and Bryne's Multifactorial Grading System for the Invasive Tumor Front) were assessed. Additionally, the organization of the extracellular matrix was analyzed by carbohydrate and collagen histochemistry, and immunohistochemistry was used to assess the expression of the tumor markers proliferating cell nuclear antigen and mutated p53. The results indicate that, despite the promising effect of quercetin in other studies, this drug is ineffective as a chemoprotective agent against 4‑NQO‑induced OSCC in mice at the assayed doses.

View Figures

View References

1	Bai LY, Weng JR, Hu JL, Wang D, Sargeant AM and Chiu CF: G15, a GPR30 antagonist, induces apoptosis and autophagy in human oral squamous carcinoma cells. Chem Biol Interact. 206:375–384. 2013. View Article : Google Scholar : PubMed/NCBI
2	Liu Y, Zha L, Li B, Zhang L, Yu T and Li L: Correlation between superoxide dismutase 1 and 2 polymorphisms and susceptibility to oral squamous cell carcinoma. Exp Ther Med. 7:171–178. 2014.PubMed/NCBI
3	Lin WJ, Jiang RS, Wu SH, Chen FJ and Liu SA: Smoking, alcohol and betel quid and oral cancer: A prospective cohort study. J Oncol. 2011:5259762011. View Article : Google Scholar : PubMed/NCBI
4	Hollows P, McAndrew PG and Perini MG: Delays in the referral and treatment of oral squamous cell carcinoma. Br Dent J. 188:262–265. 2000. View Article : Google Scholar : PubMed/NCBI
5	Taghavi N and Yazdi I: Prognostic factors of survival rate in oral squamous cell carcinoma: Clinical, histologic, genetic and molecular concepts. Arch Iran Med. 18:314–319. 2015.PubMed/NCBI
6	Vermorken JB, Remenar E, van Herpen C, Gorlia T, Mesia R, Degardin M, Stewart JS, Jelic S, Betka J, Preiss JH, et al: Cisplatin, fluorouracil and docetaxel in unresectable head and neck cancer. N Engl J Med. 357:1695–1704. 2007. View Article : Google Scholar : PubMed/NCBI
7	Ames BN and Gold LS: Endogenous mutagens and the causes of aging and cancer. Mutat Res. 250:3–16. 1991. View Article : Google Scholar : PubMed/NCBI
8	Korde SD, Basak A, Chaudhary M, Goyal M and Vagga A: Enhanced nitrosative and oxidative stress with decreased total antioxidant capacity in patients with oral precancer and oral squamous cell carcinoma. Oncology. 80:382–389. 2011. View Article : Google Scholar : PubMed/NCBI
9	Dolatabadi JE: Molecular aspects on the interaction of quercetin and its metal complexes with DNA. Int J Biol Macromol. 48:227–233. 2011. View Article : Google Scholar : PubMed/NCBI
10	Russo M, Spagnuolo C, Tedesco I, Bilotto S and Russo GL: The flavonoid quercetin in disease prevention and therapy: Facts and fancies. Biochem Pharmacol. 83:6–15. 2012. View Article : Google Scholar : PubMed/NCBI
11	Borska S, Chmielewska M, Wysocka T, DragZalesinska M, Zabel M and Dziegiel P: In vitro effect of quercetin on human gastric carcinoma: Targeting cancer cells death and MDR. Food Chem Toxicol. 50:3375–3383. 2012. View Article : Google Scholar : PubMed/NCBI
12	Kang JW, Kim JH, Song K, Kim SH, Yoon JH and Kim KS: Kaempferol and quercetin, components of Ginkgo biloba extract (EGb 761), induce caspase-3-dependent apoptosis in oral cavity cancer cells. Phytother Res. 24 Suppl 1:S77–S82. 2010. View Article : Google Scholar : PubMed/NCBI
13	Dajas F: Life or death: Neuroprotective and anticancer effects of quercetin. J Ethnopharmacol. 143:383–396. 2012. View Article : Google Scholar : PubMed/NCBI
14	Murakami A, Ashida H and Terao J: Multitargeted cancer prevention by quercetin. Cancer Lett. 269:315–325. 2008. View Article : Google Scholar : PubMed/NCBI
15	Harwood M, DanielewskaNikiel B, Borzelleca JF, Flamm GW, Williams GM and Lines TC: A critical review of the data related to the safety of quercetin and lack of evidence of in vivo toxicity, including lack of genotoxic/carcinogenic properties. Food Chem Toxicol. 45:2179–2205. 2007. View Article : Google Scholar : PubMed/NCBI
16	Yang CS, Landau JM, Huang MT and Newmark HL: Inhibition of carcinogenesis by dietary polyphenolic compounds. Annu Rev Nutr. 21:381–406. 2001. View Article : Google Scholar : PubMed/NCBI
17	Dayan D, Hirshberg A, Kaplan I, Rotem N and Bodner L: Experimental tongue cancer in desalivated rats. Oral Oncol. 33:105–109. 1997. View Article : Google Scholar : PubMed/NCBI
18	Rivera CA, Droguett DA, Kemmerling U and Venegas BA: Chronic restraint stress in oral squamous cell carcinoma. J Dent Res. 90:799–803. 2011. View Article : Google Scholar : PubMed/NCBI
19	Tang XH, Knudsen B, Bemis D, Tickoo S and Gudas LJ: Oral cavity and esophageal carcinogenesis modeled in carcinogen-treated mice. Clin Cancer Res. 10:301–313. 2004. View Article : Google Scholar : PubMed/NCBI
20	Junqueira LC, Bignolas G and Brentani RR: Picrosirius staining plus polarization microscopy, a specific method for collagen detection in tissue sections. Histochem J. 11:447–455. 1979. View Article : Google Scholar : PubMed/NCBI
21	Castillo C, López-Muñoz R, Duaso J, Galanti N, Jaña F, Ferreira J, Cabrera G, Maya JD and Kemmerling U: Role of matrix metalloproteinases 2 and 9 in ex vivo Trypanosoma cruzi infection of human placental chorionic villi. Placenta. 33:991–997. 2012. View Article : Google Scholar : PubMed/NCBI
22	Pindborg JJ, Reichert PA, Smith CJ and van de Waal I: Histological typing of cancer and precancer of the oral mucosaWorld Health Organization Histological Classification of Tumours. 2nd. Springer; Berlin: pp. 11–12. 1997
23	Tumuluri V, Thomas GA and Fraser IS: Analysis of the Ki-67 antigen at the invasive tumour front of human oral squamous cell carcinoma. J Oral Pathol Med. 31:598–604. 2002. View Article : Google Scholar : PubMed/NCBI
24	Bryne M, Boysen M, Alfsen CG, Abeler VM, Sudbø J, Nesland JM, Kristensen GB, Piffko J and Bankfalvi A: The invasive front of carcinomas. The most important area for tumour prognosis? Anticancer Res. 18:4757–4764. 1998.PubMed/NCBI
25	Beutler E, Duron O and Kelly BM: Improved method for the determination of blood glutathione. J Lab Clin Med. 61:882–888. 1963.PubMed/NCBI
26	Myoung H, Kim MJ, Lee JH, Ok YJ, Paeng JY and Yun PY: Correlation of proliferative markers (Ki-67 and PCNA) with survival and lymph node metastasis in oral squamous cell carcinoma: A clinical and histopathological analysis of 113 patients. Int J Oral Maxillofac Surg. 35:1005–1010. 2006. View Article : Google Scholar : PubMed/NCBI
27	Li L, Fukumoto M and Liu D: Prognostic significance of p53 immunoexpression in the survival of oral squamous cell carcinoma patients treated with surgery and neoadjuvant chemotherapy. Oncol Lett. 6:1611–1615. 2013.PubMed/NCBI
28	Gibellini L, Pinti M, Nasi M, Montagna JP, De Biasi S, Roat E, Bertoncelli L, Cooper EL and Cossarizza A: Quercetin and cancer chemoprevention. Evid Based Complement Alternat Med. 2011:5913562011. View Article : Google Scholar : PubMed/NCBI
29	Chen SF, Nien S, Wu CH, Liu CL, Chang YC and Lin YS: Reappraisal of the anticancer efficacy of quercetin in oral cancer cells. J Chin Med Assoc. 76:146–152. 2013. View Article : Google Scholar : PubMed/NCBI
30	Makita H, Tanaka T, Fujitsuka H, Tatematsu N, Satoh K, Hara A and Mori H: Chemoprevention of 4-nitroquinoline 1-oxide-induced rat oral carcinogenesis by the dietary flavonoids chalcone, 2-hydroxychalcone and quercetin. Cancer Res. 56:4904–4909. 1996.PubMed/NCBI
31	Priyadarsini RV, Vinothini G, Murugan RS, Manikandan P and Nagini S: The flavonoid quercetin modulates the hallmark capabilities of hamster buccal pouch tumors. Nutr Cancer. 63:218–226. 2011. View Article : Google Scholar : PubMed/NCBI
32	Ribeiro FA, de Moura CF, Gollucke AP, Ferreira MS, Catharino RR, Aguiar O Jr, Spadari RC, Barbisan LF and Ribeiro DA: Chemopreventive activity of apple extract following medium-term oral carcinogenesis assay induced by 4-nitroquinoline-1-oxide. Arch Oral Biol. 59:815–821. 2014. View Article : Google Scholar : PubMed/NCBI
33	Hanahan D and Weinberg RA: Hallmarks of cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
34	Gliszczyńska-Świglo A and Oszmianśki J: Antioxidant and prooxidant activity of food componentsFood Oxidants and Antioxidants: Chemical, Biological, and Functional Properties. Bartosz G: CRC Press; Boca Raton, FL: pp. 375–432. 2013
35	Notas G, Nifli AP, Kampa M, Pelekanou V, Alexaki VI, Theodoropoulos P, Vercauteren J and Castanas E: Quercetin accumulates in nuclear structures and triggers specific gene expression in epithelial cells. J Nutr Biochem. 23:656–666. 2012. View Article : Google Scholar : PubMed/NCBI
36	Johnson IT: Phytochemicals and cancer. Proc Nutr Soc. 66:207–215. 2007. View Article : Google Scholar : PubMed/NCBI